Development of a lipoprotein based molecular imaging MR contrast agent for the noninvasive detection of early atherosclerotic disease

[1]  A. Yanni,et al.  The laboratory rabbit: an animal model of atherosclerosis research , 2004, Laboratory animals.

[2]  P. Ridker,et al.  Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. , 2004, Circulation.

[3]  V. Fuster,et al.  Lipid-Rich Atherosclerotic Plaques Detected by Gadofluorine-Enhanced In Vivo Magnetic Resonance Imaging , 2004, Circulation.

[4]  J. Kastelein,et al.  Subclinical atherosclerosis as a target of therapy: potential role of statins. , 2004, The American journal of cardiology.

[5]  B. Uretsky,et al.  Covered stent septal ablation for hypertrophic obstruction cardiomyopathy. , 2004, Circulation.

[6]  J. Debatin,et al.  Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits , 2001, Circulation.

[7]  R. Weissleder.  Molecular imaging: exploring the next frontier. , 1999, Radiology.

[8]  T. Carew,et al.  Residence time of low-density lipoprotein in the normal and atherosclerotic rabbit aorta. , 1997, Circulation research.

[9]  P. Kovanen,et al.  Aggregation and fusion of modified low density lipoprotein. , 1996, Journal of lipid research.

[10]  F. Starr,et al.  Interaction of manganese-mesoporphyrin with oleic acid vesicles. , 1995, Biochemistry.

[11]  W D Wagner,et al.  A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Circulation.

[12]  J. Guyton,et al.  Transitional features in human atherosclerosis. Intimal thickening, cholesterol clefts, and cell loss in human aortic fatty streaks. , 1993, The American journal of pathology.

[13]  U. Schmiedl,et al.  Pharmaceutical Properties, Biodistribution, and Imaging Characteristics of Manganese-Mesoporphyrin: A Potential Hepatobiliary Contrast Agent for Magnetic Resonance Imaging , 1993, Investigative radiology.

[14]  D. Atsma,et al.  Potential of 99mTc-LDLs labeled by two different methods for scintigraphic detection of experimental atherosclerosis in rabbits. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[15]  S. Parthasarathy,et al.  Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. , 1991, The Journal of clinical investigation.

[16]  P. Alderson,et al.  Indium-111-labeled LDL: a potential agent for imaging atherosclerotic disease and lipoprotein biodistribution. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  H. Esterbauer,et al.  Biochemical, structural, and functional properties of oxidized low-density lipoprotein. , 1990, Chemical research in toxicology.

[18]  E. Reddi,et al.  Evidence for a major role of plasma lipoproteins as hematoporphyrin carriers in vivo. , 1984, Cancer letters.